We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
- New advice in the last 6 months (0)
- Updated advice in the last 6 months (0)
- In development advice (0)
Set out priority areas for quality improvement in health and social care.
- New quality standards in the last 6 months (0)
- Updated quality standards in the last 6 months (0)
- In development quality standards (0)
Guidance by programme
Review the evidence across broad health and social care topics.
Reviews the clinical and cost-effectiveness of new treatments.
Assessments of whether procedures are safe enough and work well enough for wider use in the NHS.
Advice by programme
Review the evidence and likely costs of medical devices and technologies.
Products being developed or updated
Comment on guidance in development
Current guidance in consultation
News on this topic
Larotrectinib (also called Vitrakvi and made by Bayer), is a new treatment for a range of cancers, has been recommended for use in the Cancer Drugs Fund (CDF).
Putting guidance into practice
Examples of how our guidance and standards have been put into practice in the NHS, local authorities, voluntary sector and a range of other organisations.
Showing 3 of 4 shared learning examples for this topic: